This page features the latest news about the Eli Lilly and Co BDR stock. Eli Lilly & Co. Says Head-to-Head Clinical Trial Reaffirms Efficacy of Emgality in Episodic Migraine Prevention ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback